Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you live in Doncaster and you're looking into weight loss injections, the honest answer is this: the two medicines licensed in the UK for weight management, Mounjaro (tirzepatide) and Wegovy (semaglutide), are prescription-only, which means a qualified prescriber must assess your suitability before any treatment is supplied. You do not need to travel to a clinic in Doncaster or anywhere else to get that assessment done safely. A regulated online pharmacy can complete the process from start to finish, with a real clinician reviewing your consultation the same day. These medicines work by mimicking gut hormones that signal fullness to the brain, reducing appetite and slowing how quickly the stomach empties. Clinical trials published in the New England Journal of Medicine recorded average body-weight reductions of around 20% over 72 weeks with tirzepatide at its highest dose. That kind of result draws understandable interest, and with it comes a lot of misleading information about where and how to buy these medicines, which is worth addressing directly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Two once-weekly injection medicines carry a UK licence for weight management. Mounjaro, made by Eli Lilly, is a dual GIP and GLP-1 receptor agonist, the only medicine of its kind approved for this purpose in the UK. Wegovy, made by Novo Nordisk, is a GLP-1 receptor agonist. Both slow gastric emptying and reduce appetite through hormonal pathways; they are not stimulants and they are not appetite suppressants in the old-fashioned sense. The NHS medicines page for tirzepatide gives a clear, patient-level account of how Mounjaro works and what to expect.
It is also worth knowing what is not licensed for weight loss. Ozempic contains the same active ingredient as Wegovy (semaglutide) but carries a licence for type 2 diabetes only. Sourcing it for weight loss is outside its licensed use, and any seller offering it on that basis should raise immediate concern. If you want to compare the licensed options side by side, our overview of the three main injectable treatments sets out the differences clearly.
Eligibility rests on more than a BMI number. The prescriber also looks at your medical history, any existing conditions, current medicines and whether there are reasons a particular treatment might not suit you. BMI alone has never been the whole picture.
NHS access to these medicines is phased and carries strict criteria. From June 2025, Mounjaro became available on the NHS for adults with a BMI of 40 or above alongside four or more qualifying conditions from a defined list including high blood pressure, obstructive sleep apnoea and type 2 diabetes. A second cohort (BMI 35 to 39.9 with four or more conditions) became eligible from June 2026. Criteria are lower by 2.5 kg/m² for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds. NICE technology appraisal TA1026 sets out the full qualifying framework.
A question our prescribers hear most weeks is: "I know I need it but I don't meet the NHS threshold, what can I do?" The honest answer is that private treatment through a regulated online pharmacy does not require a GP referral and has no waiting list, provided you meet the licensed eligibility criteria and are assessed as clinically suitable. For people in Doncaster who either do not meet the NHS thresholds or prefer not to wait, that is often the practical route. You can read more about how the two routes compare on our weight loss treatment overview.
This is the step that matters most, and it is where the most risk sits. Weight loss injections are prescription-only medicines; selling or supplying them without a valid prescription and a GPhC-registered pharmacy dispensing them is illegal in the UK. The MHRA has warned publicly about fake pens circulating online, some have contained insulin rather than the medicine on the label, leading to hospitalisations. In 2025, around 20 million doses of illegally traded weight-loss medicines (roughly £45 million in street value) were seized, and the first UK site manufacturing counterfeit tirzepatide pens was found and raided.
The check is simple: every legitimate online pharmacy in England has a GPhC premises registration number that you can verify at the GPhC register. If a seller cannot point you to a verifiable registration, that is the only signal you need. For context on what a genuine supply chain looks like, our guide to sourcing weight loss injections safely covers the red flags in full. The right question to ask any provider is not "how much?" first, it is "are you registered?"
Prices for private treatment vary by dose and provider. Since Eli Lilly raised Mounjaro's UK list price in September 2025, typical private monthly costs have ranged roughly £149 to £375 depending on dose. For a realistic picture of what these costs cover and what some providers leave out, the weight loss injections cost and access guide is a useful starting point.
Starting treatment is not the end of the clinical process) it is the beginning. Dose titration happens in steps over weeks or months, and each increase carries a slightly higher chance of temporary gastrointestinal side effects: nausea, loose stools, reflux and fatigue are all reported, usually most noticeable in the first few days after moving up a dose. They settle for most people. Storage matters too: both pens are refrigerated (2 to 8°C), and there is a limited period they can be kept at room temperature, the Patient Information Leaflet that comes with your pen gives the exact window; follow that rather than any general guidance online.
Injection technique is straightforward once shown, but doing it the same way each time helps. Rotating sites between the abdomen, thigh and upper arm reduces the chance of localised irritation, and cleaning the skin beforehand is standard practice. If you need supplies to support your injections at home, alcohol swabs are available from our pharmacy. Any side effects that worry you, or any questions about your dose, should go to your prescriber, not a forum, not a search engine.
If you are based in Doncaster and wondering how others in different parts of the country approach this, we have written similar guides for people in Manchester, Leicester and those looking into weight loss injections in Worcester, the process is the same wherever you are in England, because the prescription and dispensing happen through a regulated online pharmacy with next-working-day tracked delivery nationwide.
When you feel ready to take a proper clinical look at your options, speaking to our prescribers is the place to start. The consultation is free, there is no subscription, and the same clinical team that reviews your first application re-reviews every repeat order.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.